Seaport Therapeutics website screenshot

Seaport Therapeutics

Seaport Therapeutics is a Boston-based clinical-stage biopharmaceutical company developing new medicines for patients with depression, anxiety and other neuropsychiatric disorders. Its proprietary Glyph platform — licensed from the Porter Research Group at Monash University — applies lymphatic-targeting oral prodrug chemistry so that more medicine reaches the bloodstream and brain while bypassing first-pass liver metabolism and reducing side effects. The clinical pipeline includes GlyphAllo (SPT-300), an oral allopregnanolone prodrug in Phase 2 for major depressive disorder; GlyphAgo (SPT-320), an oral agomelatine prodrug in Phase 2 for generalized anxiety disorder; and Glyph2BLSD (SPT-348), a pre-clinical non-hallucinogenic 2-bromo-LSD neuroplastogen. Seaport publishes no public API, developer portal, SDK or machine-readable specification; its public web surface is a corporate WordPress site plus a hosted investor-relations subdomain.

Seaport Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Clinical Trials.

9.0/100 minimal ▬ flat Agent 0/100 human only saas Full breakdown ↓
scored 2026-09-02 · rubric v0.18.0
0 APIs
CompanyBiotechnologyPharmaceuticalsLife SciencesClinical TrialsNeuroscienceDrug Delivery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-02 · rubric v0.18.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/seaport-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Seaport Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

Commercial 2

Pricing, plans, and the legal terms of use

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: seaport-therapeutics
name: Seaport Therapeutics
description: Seaport Therapeutics is a Boston-based clinical-stage biopharmaceutical company developing new medicines for
  patients with depression, anxiety and other neuropsychiatric disorders. Its proprietary Glyph platform — licensed from the
  Porter Research Group at Monash University — applies lymphatic-targeting oral prodrug chemistry so that more medicine reaches
  the bloodstream and brain while bypassing first-pass liver metabolism and reducing side effects. The clinical pipeline includes
  GlyphAllo (SPT-300), an oral allopregnanolone prodrug in Phase 2 for major depressive disorder; GlyphAgo (SPT-320), an oral
  agomelatine prodrug in Phase 2 for generalized anxiety disorder; and Glyph2BLSD (SPT-348), a pre-clinical non-hallucinogenic
  2-bromo-LSD neuroplastogen. Seaport publishes no public API, developer portal, SDK or machine-readable specification; its
  public web surface is a corporate WordPress site plus a hosted investor-relations subdomain.
url: https://raw.githubusercontent.com/api-evangelist/seaport-therapeutics/refs/heads/main/apis.yml
deliveryModel:
  model: saas
  open_source: false
  commercial: true
  callable_host: false
  label: Hosted service · you call their endpoint
  confidence: medium
  source:
  - pricing
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://seaporttx.com/wp-content/uploads/2023/11/seaport_logo.png
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Neuroscience
- Drug Delivery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/seaport-therapeutics-domain-security.yml
- type: Website
  url: https://seaporttx.com/
- type: PrivacyPolicy
  url: https://seaporttx.com/privacy-policy/
- type: TermsOfService
  url: https://seaporttx.com/terms-of-use/
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Seaport Therapeutics is a clinical-stage neuropsychiatric drug developer whose product is the Glyph oral-prodrug
    platform, not software; seaporttx.com is a corporate WordPress site that returns a real 404 on every OpenAPI, GraphQL,
    llms.txt and /.well-known/ path, and its only machine-readable document is the WordPress core /wp-json/ discovery index
    that ships with the CMS.
  evidence:
  - url: https://seaporttx.com/openapi.json
    status: 404
  - url: https://seaporttx.com/llms.txt
    status: 404
  - url: https://seaporttx.com/.well-known/agent-card.json
    status: 404
  - url: https://seaporttx.com/wp-json/
    status: 200
  - url: https://investors.seaporttx.com/
    status: 0
  checked: '2026-08-26'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/seaport-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/seaport-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/seaport-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.